Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Benitec Biopharma Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 57 | 56 | −1 |
| Shares | 22.7M | 23.2M | +469.7K (+2.1%) |
| Value | $265.3M | $324.7M | +$59.4M (+22.4%) |
New holders (6)
Institutions that held Benitec Biopharma Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Russell Investments Group, Ltd. | 5,615 | $78.8K | 0.00% |
| SRS Capital Advisors, Inc. | 24 | $337 | 0.00% |
| The PNC Financial Services Group, Inc. | 5 | $70 | 0.00% |
| IFP Advisors, Inc | 1 | $14 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $14 | 0.00% |
| CWM, LLC | 17 | $0 | 0.00% |
Sold out (7)
Institutions that held Benitec Biopharma Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Marshall Wace, LLP | 43,003 | $503.1K |
| EAM Investors, LLC | 37,809 | $442.4K |
| Susquehanna International Group, LLP | 17,728 | $207.4K |
| Anson Funds Management LP | 11,710 | $137.0K |
| XTX Topco Ltd | 10,845 | $126.9K |
| Acadian Asset Management LLC | 1,817 | $21.0K |
| EverSource Wealth Advisors, LLC | 148 | $1.73K |